• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Obesity, Research
←Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America
The Trump-Backed Federal Budget Threatens Black Economic Progress. Here’s How Black Communities Can Reclaim Their Power→

More posts

  • iHeartMedia Shares Jump After Report Of Early Merger Talks With SiriusXM

  • Mamdani reflects on ‘important’ relationship with Trump during MS NOW town hall

  • Altman apologizes after OpenAI failed to alert police before Tumbler Ridge killings

  • ‘Below Deck’ Transport Vessel Catches Fire at Sea, On Video

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube